| Regents Approve Funding for Construction
of Clinical Cancer Center Building 
An artist's rendering of the
clinical cancer building at UCSF
Mount Zion Medical Center.
The University of
California Board of Regents approved financing for the
construction of a long-awaited clinical cancer center
building at the UCSF Mount Zion Medical Center.
The five-story,
88,000-square-foot building will be at the corner of
Sutter and Divisadero streets and will house clinical
cancer programs of UCSF Mount Zion Medical Center, part
of UCSF Stanford Health Care. The new facility will
include a state-of-the-art radiation therapy center, a
patient-oriented breast care center, mammography,
chemotherapy and doctors' offices.
The Regents approved bond
financing of $33 million for the UCSF Cancer Center
building at their February 19 meeting in San Francisco.
The new building has a total project cost of $42.5
million, which includes $10 million to be obtained
through private fundraising.
Bond financing for the new
UCSF Mount Zion building is part of a $338.4 million
capital construction and debt restructuring bond package
for UCSF Stanford Health Care. The UC Regents and the
Stanford University Board of Trustees each have approved
the bond package.
The plan calls for $47
million in bond financing for an ambulatory care center
at Stanford that also will provide cancer treatment. The
total cost of the Stanford project will be $117 million,
of which $50 million will come through private
fundraising and $20 million from regular capital
programs.
The two centers, at UCSF
and Stanford, are needed to accommodate growth in cancer
care as well as to consolidate clinical services in
adjacent space.
"The building of the
cancer center, done in parallel with complementary
efforts at Stanford, is a major step toward integrating
cancer research and the clinical environment. Together,
we expect to build a first-class cancer center for
Northern California over the next five years," said
Frank McCormick, director of the UCSF Cancer Center.
UCSF Stanford Chief
Executive Officer Peter Van Etten also cited the
complementary nature of the projects and their shared
goal of transforming laboratory discoveries into new
treatments as quickly as possible.
"The plans build on
the collective strengths of the two institutions and are
in keeping with the mission of UCSF Stanford Health Care
to provide cutting-edge treatment capabilities and to
improve and innovate in the area of patient care,"
Van Etten said.
Long known as a major
center for basic cancer research, UCSF is working to
enhance clinical research by arranging to provide access
to both clinical care and trials under one roof. UCSF
opened its new cancer research building in 1997 and is
continuing to recruit nationally recognized cancer
researchers for the facility. The goal is to become the
first National Cancer Institute (NCI)-designated
comprehensive cancer center in Northern California. Such
a designation would allow the center to receive more
grants and conduct more clinical trials to serve patients
in Northern California. UCSF expects to apply for the
designation this year.
"With this new
project, we will be able to offer interdisciplinary care
that is unique in the Bay Area. We are bringing together
the scientific community with clinicians to provide the
most up-to-date clinical protocols for people in Northern
California," according to Bruce Schroffel, chief
operating officer of the UCSF Medical Center.
Groundbreaking for the new building will take place by
June 1 and construction should be completed by the end of
1999, he said.
"It should be an
elegant building," Schroffel said, noting that
planners are studying a proposal for a two-story atrium
that will be the focal point of the entry and also will
function as a new entry for the entire UCSF Mount Zion
Medical Center.
Preliminary plans call for
the building exterior to be accented by large glass bay
windows offset by brick. A patient drop-off canopy also
will be provided in front of the existing hospital entry.
by Dale Martin
1st appeared 2/24/98
RETURN TO TOP
|